BioPharm International: Meeting Challenges in Contract R&D

Mar 02 2012

BioPharm International

Representatives from leading contract research organizations (CROs) weigh in on key challenges tied to the biopharmaceutical R&D, including issues regarding bioequivalence, platform technologies, process analytics, and more. Charles River’s Nancy Gillett, PhD, corporate executive vice-president and president of Global Preclinical Services, participated in this roundtable.  

Click here to read the full article.